Technical Data
B0077-02A
BAP31, Control Peptide (B Cell Receptor-Associated Protein 31, BCR-Associated Protein, p28, CDM Protein, 6C6-AG Tumor-associated Antigen, DXS1357E)
50ug
|
Technical Data |
|
B0077-02A |
BAP31, Control Peptide (B Cell Receptor-Associated Protein 31, BCR-Associated Protein, p28, CDM Protein, 6C6-AG Tumor-associated Antigen, DXS1357E) |
50ug |
| Molecular Biology | Storage: -20°CShipping: Blue Ice |
|
Synthetic peptide BAP31 17aa near the center of human BAP31 (Genbank accession No. NP_005736). Applications: Suitable for use in Western Blot. Other applications not tested. Recommended Dilution: Western Blot: 0.5-1ug’ml; Blocks the antibody (Cat. #B0077-02) activity completely by incubating the peptide with equal volume of antibody for 30 min at 37°C. Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
Purity: Purified Concentration: ~0.2mg/ml Form: Supplied as a liquid in PBS, pH 7.2, 0.1% BSA, 0.02% sodium azide. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
1. Kim KM, Adachi T, Nielsen PJ, et al. Two new proteins preferentially associated with membrane immunoglobulin D. EMBO J. 1994; 13:3793-800.
|
||